Track topics on Twitter Track topics that are important to you
WASHINGTON (dpa-AFX) - Alexion Pharmaceuticals Inc. (ALXN) and Sema4 announced a strategic partnership to leverage their shared experience in data science and systems biology to accelerate rare di...
Original Article: Alexion,Sema4 Partner In Rare Disease Diagnostics And Systems BiologyNEXT ARTICLE
Mergers & Acquisitions
Commercial and market reports on mergers and acquisitions in the biotechnology, pharmaceutical, medical device and life-science industries. Mergers and acquisitions (abbreviated M&A;) is an aspect of corporate strategy, corporate finance and manageme...